BioSpace News Archive

Recipharm announced on 4 February 2020 that the offer to acquire Consort Medical plc had become unconditional in all respects and will remain open for acceptances for a further 14 days, until 18 February 2020.

A strong development in fourth quarter earnings, combined with the licensing deal with Zimmer Biomet led to the highest full-year result in Bactiguard’s history.

AccelTRA® Component Line Extensions, New Container Closure System and Ready Pack™ System Featuring SCHOTT iQ® Platform Bring Greater Value to Global Customers, Advance West Industry Leadership

Progenity, a biotechnology company developing precision medicine solutions across genomic/epigenomic, proteomic, and microbiomic diagnostic and therapeutic platforms, will present results from a retrospective clinical laboratory analysis, which indicated that noninvasive prenatal testing performs well for predicting aneuploidies in twin pregnancies.

As Threats Increase, Annual Assessment Finds States’ Level of Readiness for Health Emergencies is Improving in Some Areas but Stalled in Others

Funding enables expansion of clinical program to include additional cancer indications and development of a capsule formulation of MaaT Pharma’s full-ecosystem therapeutic

Abalos Therapeutics announced the appointments of Dr. Klaus Binder as Chairman of the Board and Dr. Dethardt Müller as Chief Technology Officer to rapidly advance and build out the company’s drug discovery and manufacturing efforts for novel arenavirus-based cancer therapeutics.

Boston Scientific Corporation generated sales of $2.905 billion during the fourth quarter of 2019.

Dr. McIvor, Chief Development Officer, to present on the Sleeping Beauty-Engineered B Lymphocytes ISP™ platform

Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, today announced that Carrie Bourdow, President and Chief Executive Officer, will present a corporate overview at the BIO CEO & Investor Conference, being held at the Marriott Marquis Times Square on February 10th-11th, 2020, in New York City.